FFAR3 and Alzheimer disease: In that study, Zamarbide et al. showed that FFAR3 mRNA levels are increased, while FFAR1 and FFAR2 appeared to be downregulated in early stages of the AD pathology, reasoning that FFAR3 could play a key role in AD onset and progression.